Conference: 2026 SNMMI Annual Meeting
日期: May 30 - 2026 年 6 月 2 日
地点: Los Angeles, CA
展位: 533

Mirjam Trame
VP, Certara Drug Development Solutions, Head of Pharmacometrics USA – Division IIMirjam 是一名药物代谢动力学顾问,在 Certara 公司担任美国药代动力学 II 部门总监。她拥有涵盖多种模式的专业知识,包括复杂生物制剂,并专注于细胞和基因疗法领域。

Hunter Stephens, PhD
副总监Hunter Stephens, PhD, is an Associate Director in the Pharmacometrics group at Certara. He specializes in applying mathematical and computational models to understand the pharmacokinetics and pharmacodynamics of drugs, especially radiopharmaceuticals. He has a PhD in Medical Physics from Duke University. He also holds an MS in Physics from North Carolina State University and a BS in Mathematics from Tennessee Tech University. His work in TRT has focused on building semi-mechanistic population PK models to simulate and predict absorbed and biologically effective doses to inform dose-range finding and questions of safety and efficacy. In addition, he has extensive experience in radiation dosimetry from external and internal sources.

Joshuaine Grant
Sr. Director, QSPJoshuaine Grant is a Senior Director in Quantitative Systems Pharmacology at Certara with more than 25 years of experience integrating biophysics, disease biology, and quantitative modeling to advance drug development. She leads collaborative projects that use mechanistic and translational QSP modeling to inform key decisions from discovery through the clinic. Her broad experience across biologics and complex therapeutics has supported Certara’s growing leadership in radioligand and targeted radiotherapies.
Global Account Director
Based in San Diego, Bill is a Director of Business Development for the West Coast. Leveraging extensive nonclinical experience, he helps clients utilize Certara’s services from predictive modeling to market access strategies to enhance their decision-making. Bill is dedicated to making every drug the safer bet.



